American Chemical Society
|Agreement labeling||ACS Read and Publish Agreement|
|Has the agreement been disclosed and published?||Yes|
|Agreement period||01/01/2021 – 12/31/2025|
|Consortia / Institution||IReL|
Approximate range of annual corresponding author publications
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Full cost is based on subscriptions|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|Risk sharing element is explained in the agreement: see Schedule 5.c|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||Yes|
|OA LICENSE||CC-BY mandatory|
||Original research articles
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
|Comments on access costs||100% of cost is based on access|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|WORKFLOW ASSESSMENT||Too early to assess|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|